Videoconference-Based Cognitive Behavioral Therapy in Medication-Treated Adults with Attention-Deficit/Hyperactivity...

Area of Science:

• Neuroscience
• Psychiatry
• Digital Health

Background:

• Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder extending into adulthood.
• While pharmacotherapies are common for ADHD, they present challenges like side effects and dropout.
• Videoconference-based cognitive behavioral therapy (vCBT) offers a promising, accessible alternative for ADHD management.

Purpose of the Study:

• To evaluate the efficacy of vCBT for adults with ADHD.
• To compare vCBT plus treatment-as-usual (TAU) against TAU alone.
• To assess vCBT's impact on ADHD symptoms, quality of life, and functional impairment.

Main Methods:

• A randomized, assessor-blinded, controlled trial was conducted.
• Thirty adults with ADHD were randomized to 12 sessions of vCBT + TAU or TAU alone.
• Primary outcome: change in ADHD Rating Scale-IV (ADHD-RS-IV) total score at 12 weeks.

Main Results:

• The vCBT group showed a significantly greater reduction in ADHD-RS-IV scores compared to the TAU group (p=0.0007).
• vCBT led to significant improvements in self-reported inattention, hyperactivity, and impulsivity.
• Enhanced quality of life and work/school performance were observed in the vCBT group.

Conclusions:

• vCBT is an effective and accessible intervention for adults with ADHD.
• vCBT demonstrates efficacy in reducing core ADHD symptoms and improving functional outcomes.
• vCBT serves as a valuable alternative treatment for adults with ADHD, especially those with residual symptoms post-pharmacotherapy.